Literature DB >> 25761318

The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden.

Gianluca Gessoni1,2, Sara Valverde1, Francesca Gessoni2, Roberto Valle3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25761318      PMCID： PMC4624546          DOI： 10.2450/2015.0224-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  8 in total

1.  Factor V Leiden in Chioggia: a prevalence study in patients with venous thrombosis, their blood relatives and the general population.

Authors:  Gianluca Gessoni; Sara Valverde; Rosa Canistro; Fabio Manoni
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

2.  Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.

Authors:  Jonathan Douxfils; François Mullier; Séverine Robert; Christian Chatelain; Bernard Chatelain; Jean-Michel Dogné
Journal:  Thromb Haemost       Date:  2012-03-22       Impact factor: 5.249

3.  The effect of dabigatran on select specialty coagulation assays.

Authors:  Dorothy M Adcock; Robert Gosselin; Steve Kitchen; Denis M Dwyre
Journal:  Am J Clin Pathol       Date:  2013-01       Impact factor: 2.493

4.  Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.

Authors:  Tomas L Lindahl; Fariba Baghaei; Inger Fagerberg Blixter; Kerstin M Gustafsson; Lennart Stigendal; Margareta Sten-Linder; Karin Strandberg; Andreas Hillarp
Journal:  Thromb Haemost       Date:  2010-11-23       Impact factor: 5.249

5.  Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

Authors:  A Hillarp; F Baghaei; I Fagerberg Blixter; K M Gustafsson; L Stigendal; M Sten-Linder; K Strandberg; T L Lindahl
Journal:  J Thromb Haemost       Date:  2011-01       Impact factor: 5.824

6.  Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.

Authors:  Gianluca Gessoni; Sara Valverde
Journal:  Blood Coagul Fibrinolysis       Date:  2007-10       Impact factor: 1.276

Review 7.  Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature.

Authors:  Jonathan Douxfils; François Mullier; Claire Loosen; Christian Chatelain; Bernard Chatelain; Jean-Michel Dogné
Journal:  Thromb Res       Date:  2012-09-21       Impact factor: 3.944

8.  Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.

Authors:  G Gessoni; S Valverde; R Canistro; E Trabuio; F Antico; F Manoni
Journal:  Minerva Med       Date:  2007-04       Impact factor: 4.806
  8 in total
  1 in total

1.  Effect of dabigatran on a prothrombinase-based assay for detecting activated protein C resistance: an ex vivo and in vitro study in normal subjects and factor V Leiden carriers.

Authors:  Gianluca Gessoni; Sara Valverde; Letizia Valle; Pierpaolo Caruso; Francesca Gessoni; Roberto Valle
Journal:  Blood Transfus       Date:  2017-03-07       Impact factor: 3.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.